Pharvaris reports Q4 results
Source: SeekingAlpha
2026-04-02 07:05:00 ET
More on Pharvaris
- Pharvaris N.V. (PHVS) Presents at 2026 Global Angioedema Leadership Conference - Slideshow
- Pharvaris N.V. (PHVS) Presents at American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 Annual Meeting - Slideshow
- Seeking Alpha’s Quant Rating on Pharvaris
- Historical earnings data for Pharvaris
- Financial information for Pharvaris
Read the full article on Seeking Alpha
For further details see:
Pharvaris reports Q4 results
Pharvaris N.V.
NASDAQ: PHVS
PHVS Trading
1.18% G/L:
$28.68 Last:
5,332 Volume:
$29.14 Open:
PHVS Latest News
April 13, 2026 10:44:04 am
Pharvaris' CEO Dumped Over 23,000 Company Shares. Here's What That Means for Investors.April 02, 2026 06:50:00 am
Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatePHVS Stock Data
$1,492,567,159
37,790,994
N/A
37
N/A
Biotechnology & Life Sciences
Healthcare
NL
Leiden
